InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（1 笔）
内部人交易记录
董事已披露买入
4
已披露卖出
1
T+90 胜率
100%
T+90 平均收益
+5.8%
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Explore the full record of transactions filed by Hughes Owen, 董事. Officer active across 5 companies, notably Translate Bio, Inc.. Aggregated, 17 reports have been published. Breakdown: 4 buys · 1 sell. Total volume traded: €2.2m. Activity tracked since 23 December 2021. The latest transaction was filed on 20 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hughes Owen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
191,264 股Common StockSEC:0001193125-26-303725:0
752 股Common StockSEC:0001193125-26-303725:1
102,000 股Depositary Shares - 8.375% Series B Cumulative StockSEC:0001193125-26-303725:2
10,568 股0Common StockSEC:0001214659-26-004969:0
82,428 股0Common StockSEC:0001214659-26-003399:0
100,000 股@ US$25.05100.0% 占其流量Depositary Shares - 8.375% B Cumulative StockSEC:0001214659-25-017720:0
标准退出：2026年3月4日 (T+90)
35,567 股0Common StockSEC:0001214659-25-014068:0
53,359 股0Common StockSEC:0001214659-25-008201:0
53,360 股0Common StockSEC:0001214659-24-018899:0
1,000 股@ US$13.8375.2% 占其流量Common StockSEC:0001214659-23-013141:0
标准退出：2023年12月31日 (T+90)
1 股@ US$14.650.1% 占其流量Common StockSEC:0001214659-23-012683:0
标准退出：2023年12月24日 (T+90)
200 股@ US$23.3324.7% 占其流量Depositary Shares - 8.375% B Cumulative StockSEC:0001214659-23-007824:0
标准退出：2023年8月21日 (T+90)
21,650 股@ US$10.00100.0% 占其流量Common StockSEC:0000899243-22-028649:0
5,500 股0Common StockSEC:0001209191-22-004788:0
30,000 股0Class A Common StockSEC:0001213900-21-068108:0
52,500 股0Class A Common StockSEC:0001213900-21-067727:0
29,860 股@ €32.189850.0% 占其流量Common StockSEC:0001209191-21-056049:0
17 条申报中的 17 条
About Hughes Owen
Hughes Owen is Administrateur and has 17 filings in total. In the sampled recent filings held, the transactions are option exercises, with buys of EUR 2164653 and no sells, from 2021-09-14 to 2026-07-14. The companies mentioned in the recent filings include XOMA Royalty Corp, XOMA Corp and Radius Health, Inc.
